CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

Explore the PTAB proceeding IPR2023-01044 filed by Novartis Gene Therapies, Inc. et al. on 2023-06-30. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-01044

Filing Date

2023-06-30

Accorded Filing Date

2023-06-30

Institution Decision Date

2024-01-09

Last Modified Date

2024-03-04

Proceeding Type

IPR

Termination Date

2024-03-04

Trial Status

Terminated-Settled

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 15544498
Respondent Patent Number 10429288
Legal Expiration Date
2036-01-19 Active (9.2 yrs remaining)
Injunction Viability (35 U.S.C. § 283) Active Threat
Respondent Inventor Catherine R. O'RIORDAN et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

2 Total

Proceeding Status

Terminated-Settled

Board Decisions & Rulings (2)

Settled After Institution 2024-03-04
Termination Decision: Post-DI Settlement
37 CFR 42.72, 37 CFR 42.74, 35 USC 317
Institution Granted 2024-01-09
DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314, 37 C.F.R. § 42.4
35 USC 312, 35 USC 314, 37 CFR 42.100, 37 CFR 42.108

Address and Attorney/Agent Information

40 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name LISA P. RASMUSSEN - SANOFI
Customer Number 5487
Address 450 WATER STREET, Cambridge, MA, 02141, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
36844 Joseph Kirk Jr +1 908-981-6911
39150 John Conway +1 908-981-6688
40564 Anne Collins +1 978-341-0036
44045 Sandra Brockman-Lee +1 857-523-9199
45736 Pamela Torpey +1 508--27-1-0683
45979 Milan Vinnola +1 619-238-0062
47150 Nicole Parsons +1 617-685-5697
52610 Kelly Bender +1 248-593-0581

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 1 U.S. Courts: 1
USPTO PTAB Trial 2023-06-30
IPR2023-01045

Novartis Gene Therapies, Inc. et al. v. Aventis, Inc. et al.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2023-05-19
1:23-cv-00554

Genzyme Corporation v. Novartis Gene Therapies, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

51
20

Termination Decision: Post-DI Settlement TERMINATE

2024-03-04 FILING PARTY: BOARD
18

Joint Request That Settlement Agreement Be Treated As Business Confidential Information And Kept Separate MOTION

2024-02-26 FILING PARTY: PETITIONER
19

Petitioners' Updated Exhibit List NOTICE

2024-02-26 FILING PARTY: PETITIONER
17

Joint Motion to Terminate MOTION

2024-02-26 FILING PARTY: PETITIONER
16

Order: Authorizing the Filing of a Joint Motion to Terminate - 35 USC 317;,37 CFR 42.20(b), 42.72 ORDER

2024-02-21 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc